Leading the Way in Diabetes Care, and in the Discussion of How to Pay for ItByAn Interview with John L. Brooks III, CEO,President, Joslin Diabetes CenterDecember 16th 2013
FDA Tells Direct-to-Consumer Genetic Testing Company to Halt MarketingByMary K. CaffreyDecember 14th 2013
Incretin Mimetics: Pros and Cons, and Emerging Agents in Diabetes TreatmentByJamie M. Terrell, PharmD,Tibb F. Jacobs, PharmD, BCPSDecember 14th 2013Drug Pipeline
Amid Uproar Over Term Artificial Pancreas, How Will Patients, Payers Respond?ByAndrew SmithDecember 14th 2013
Will NYC's New Mayor Follow Through on Soda Limits?ByPeter PageDecember 14th 2013With Science Reaching Consensus on Health Effects of Sugary Drinks, Talk of Portion Caps and Taxes Gains Steam Globally